Current Molecular Pharmacology
Title:Preface:
Volume: 9
Author(s): Michael Kahn
Affiliation:
Export Options
About this article
Cite this article as:
Kahn Michael, Preface:, Current Molecular Pharmacology 2016; 9 (1) . https://dx.doi.org/10.2174/187446720901151207152902
DOI https://dx.doi.org/10.2174/187446720901151207152902 |
Print ISSN 1874-4672 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4702 |
29
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Spontaneous Coronary Artery Dissection: Does Being Unemployed Matter? Insights from the GSCAD Registry
Current Cardiology Reviews GP IIb / IIIa Blockade in Elective Percutaneous Coronary Intervention
Current Pharmaceutical Design Lipid Nanocarriers and Molecular Targets for Malaria Chemotherapy
Current Drug Targets The J-shaped Association Between Alcohol Consumption and Breast Cancer: A Case-Control Study
Current Nutrition & Food Science HspB5/αB-Crystallin: Properties and Current Progress in Neuropathy
Current Neurovascular Research Emerging P2Y12 Receptor Antagonists: Role in Coronary Artery Disease
Current Vascular Pharmacology COVID-19 Infection in Pregnancy: A Review
Infectious Disorders - Drug Targets Renovascular Hypertension: Novel Insights
Current Hypertension Reviews Editorial [Carotid Intima-Media Thickness and Ezetimibe: The End of a Misunderstanding?]
Current Vascular Pharmacology Pharmacological Interventions on Asymmetric Dimethylarginine, a Clinical Marker of Vascular Disease
Current Medicinal Chemistry Intrauterine Intervention for the Treatment of Fetal Growth Restriction
Current Pediatric Reviews Human Tissue Kallikrein: A New Bullet for the Treatment of Ischemia
Current Pharmaceutical Design L-Arginine Signalling Potential in the Brain: The Peripheral Gets Central
Recent Patents on CNS Drug Discovery (Discontinued) Targeted Drugs and Nanomedicine: Present and Future
Current Pharmaceutical Design Vasoproliferation and Antiproliferative Treatment Options in Pulmonary Arterial Hypertension
Recent Patents on Cardiovascular Drug Discovery Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Targeting Conserved Pathways: Mitochondrial Dysfunction and Beyond
Current Neurovascular Research Carotid Artery Atherosclerosis: What is the Evidence for Drug Action?
Current Pharmaceutical Design Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimers Disease
Current Neuropharmacology Anticoagulant Therapy in Pregnant Patients with Metabolic Syndrome: A Review
Current Pharmaceutical Biotechnology